NT-proBNP聯(lián)合心臟超聲在維持性血液透析(MHD)心力衰竭診斷價值
[Abstract]:objective
To study the changes of plasma NT-proBNP level in the patients with different heart failure in the maintenance hemodialysis patients, and to combine the ventricular structure, hemodynamics and function changes of the patients with the echocardiography to provide the basis for the diagnosis and treatment of the patients with heart failure in the maintenance hemodialysis patients.
Information and methods
All the patients were enrolled in a total of 110 patients undergoing hemodialysis and complete data during the period from September 2012 to October 2013 in Zaozhuang municipal hospital. All patients were dialysis 2-3 times a week, each time of 4H for each dialysis period. For more than 4 months, all.110 patients underwent routine blood related index examination, NT-proBNP and color Doppler echocardiography simultaneously.
Hematological examination: NT-ProBNP, urea nitrogen, blood creatinine, blood calcium, hemoglobin, erythrocyte specific volume and so on. Pre hemodialysis specimens were collected before the start of hemodialysis. It was not yet connected to the extracorporeal circulation device. The heparin anticoagulant was not used, the forearm vein was extracted from the upper limb of the patient. The blood samples were collected at the end of the hemodialysis. All blood samples were taken immediately after blood sampling and tested by automated analyzer. The hematological results before dialysis were used as the observation index of this study, and Kt/V. was calculated according to the blood biochemistry before and after dialysis.
MHD patients sit in 10min, extract 2M1 from peripheral venous blood before hemodialysis, take 2000r/min after 2000r/min, and determine the level of NT-proBNP in the patient's serum by electrochemiluminescence immunofluorescence.
All patients were using the American GE formula V70 intelligence Star color Doppler echocardiography to detect the heart with a probe frequency of 2 to 4.3 hertz. Under conventional ultrasound, LAD, LVEDd, LVESD, IVST, LVPWT, LVEP, and LVMI. according to Devereux and Reichek formulas
Result
1, three groups of MHD patients, compared with 22, were compared in age, sex, weight, body mass index, dialysate age, systolic pressure, diastolic pressure, blood creatinine, urea nitrogen, hemoglobin, serum albumin and Kt/V, and the value of P was 0.05, the difference was not statistically significant.
2, HF in patients with MHD had positive correlation with NT-proBNP, LVEF, LVEDd, and dialysate weight growth rate, of which the correlation coefficient of NT-proBNP was 0.571, P was 0.008, the correlation coefficient of LVEF was 0.472, and P was 0.005, indicating that NT-proBNP and LVEF were correlated with.MHD patients. There were clinical symptoms of heart failure and age, blood There was no correlation between HGB, dialysis age, urea nitrogen, serum creatinine and serum albumin.
3, MHD heart function D and C, C and B, B and class a P value compared with the level of NT-proBNP, the difference is statistically significant. And with the increase of the degree of HF in maintenance hemodialysis patients, NT-ProBNP level is significantly higher.
4. NT-proBNP levels were positively correlated with LVEDd, LVMI and SBP, negatively correlated with hemoglobin, hematocrit and LVEF, but not with dialysis age and LVPWT (P 0.05).
5, LVEF, LVEDd statistical values in the heart function D and C, C and B, B and a P value compared to 0.05, the difference is statistically significant; the details of table 6. with HF, LVEF is gradually decreasing trend, LVEDd gradually increase.
6, the sensitivity of NT-proBNP for MHD heart failure was 84.6%, the specificity was 57.2%, and the applied echocardiography was 67.4% and 68.9%, and the combined diagnosis was 92.3%, 73.3%., respectively.
conclusion
1, the heart failure of MHD patients was positively correlated with NT-proBNP, and the significant negative correlation between NT-proBNP and LVEF could lead to the decrease of LVEF, the higher the degree of failure, the lower the LVEF, the higher the elevation of NT-proBNP, the gradual decrease of LVEF, and the increase of LVEDd.
2, the elevation of NT-proBNP level is associated with left ventricular diastolic dysfunction, ventricular remodeling and hypertension, but not related to the age of dialysis in patients, which can effectively indicate the degree of HF lesions and failure in MDH patients.
3, NT-proBNP combined with echocardiography, such as LVEDd, LVMI, and SBP, can significantly improve the sensitivity and specificity for the diagnosis of cardiac failure in MHD patients, which is of great significance for the diagnosis of HF in MDH patients.
【學(xué)位授予單位】:山東大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R445.1;R692.5
【參考文獻】
相關(guān)期刊論文 前10條
1 吳玲;石曉燕;;N末端B型腦鈉肽在老年心衰診斷中應(yīng)用分析[J];安徽醫(yī)學(xué);2011年07期
2 杜春玲;申屠磊華;胡紅梅;;血液透析間期并發(fā)急性左心衰竭的原因分析及護理對策[J];護士進修雜志;2008年04期
3 趙洪梅;羅雙莉;王俊紅;王術(shù)花;;血液透析患者心力衰竭后動靜脈內(nèi)瘺閉塞原因分析及護理[J];護士進修雜志;2011年21期
4 夏朝紅;;N末端-前B型鈉尿肽檢測在診斷ACS中的臨床應(yīng)用[J];放射免疫學(xué)雜志;2012年03期
5 吳碧紅;蔡早育;潘潔茹;;N末端B型鈉尿肽原及白細胞介素-6在糖尿病腎病診斷中的臨床意義[J];廣東醫(yī)學(xué);2011年12期
6 汪隆海;張平;陳啟松;;定量檢測N末端腦鈉肽對心衰的診斷價值[J];國際檢驗醫(yī)學(xué)雜志;2009年01期
7 龔國忠;劉友迎;蒲澤晏;唐川蘇;魏容;楊瀚喧;;N末端B型鈉尿肽原在急性心肌梗死所致心力衰竭中的臨床意義[J];重慶醫(yī)學(xué);2013年12期
8 楊芳;陳瑯;沈曉麗;郭薇;;N端腦鈉肽前體在小兒川崎病診斷中的價值[J];臨床兒科雜志;2010年07期
9 王亮;冷文修;何昆侖;范利;;腦鈉肽和N末端腦鈉肽前體在老年舒張性心力衰竭患者中的比較[J];中華老年心腦血管病雜志;2008年06期
10 陰淑瑩;薛明明;魏芳晶;;心力衰竭病人NT-proBNP與心功能水平相關(guān)性研究[J];內(nèi)蒙古醫(yī)學(xué)院學(xué)報;2010年03期
,本文編號:2169281
本文鏈接:http://sikaile.net/yixuelunwen/fangshe/2169281.html